Capital Analysts LLC’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Buy
518
+1
+0.2% +$23 ﹤0.01% 1266
2026
Q1
$11K Buy
517
+1
+0.2% +$17 ﹤0.01% 1237
2025
Q4
$6K Buy
516
+2
+0.4% +$26 ﹤0.01% 1313
2025
Q3
$8K Buy
514
+212
+70% +$3.08K ﹤0.01% 1234
2025
Q2
$3K Buy
+302
New +$3.4K ﹤0.01% 1287
2023
Q3
Sell
-14
Closed -$1K 1171
2023
Q2
$1K Buy
+14
New +$427 ﹤0.01% 964
2023
Q1
Sell
-190
Closed -$6K 979
2022
Q4
$6K Sell
190
-106
-36% -$3.18K ﹤0.01% 887
2022
Q3
$8K Buy
296
+9
+3% +$297 ﹤0.01% 834
2022
Q2
$9K Buy
287
+107
+59% +$3.94K ﹤0.01% 806
2022
Q1
$6K Buy
180
+2
+1% +$63 ﹤0.01% 798
2021
Q4
$6K Buy
178
+114
+178% +$3.55K ﹤0.01% 859
2021
Q3
$2K Buy
+64
New +$2.07K ﹤0.01% 922
2021
Q1
Sell
-69
Closed -$2K 1069
2020
Q4
$2K Hold
69
﹤0.01% 684
2020
Q3
$1K Hold
69
﹤0.01% 727
2020
Q2
$1K Hold
69
﹤0.01% 679
2020
Q1
$1K Hold
69
﹤0.01% 654
2019
Q4
$1K Hold
69
﹤0.01% 694
2019
Q3
$1K Sell
69
-55
-44% -$895 ﹤0.01% 668
2019
Q2
$3K Buy
124
+55
+80% +$1.62K ﹤0.01% 606
2019
Q1
$2K Buy
69
+14
+25% +$509 ﹤0.01% 602
2018
Q4
$2K Hold
55
﹤0.01% 545
2018
Q3
$2K Hold
55
﹤0.01% 517
2018
Q2
$2K Sell
55
-55
-50% -$2.74K ﹤0.01% 541
2018
Q1
$5K Buy
+110
New +$5.5K ﹤0.01% 496

Other funds holding CC

Capital Analysts LLC's CC Position: Q2 2026 in Review

Capital Analysts LLC increased its Chemours (CC) stake by 0.19% in Q2 2026, buying an estimated $23 and bringing the position to 518 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Capital Analysts LLC first reported a position in CC in Q1 2018 and has held it in 24 quarters since. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Capital Analysts LLC held 518 shares of Chemours worth $11K as of Q2 2026.
  • Capital Analysts LLC bought 1 Chemours share in Q2 2026, an estimated $23.
  • Chemours made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1266 holding.
  • Capital Analysts LLC first reported a position in Chemours in Q1 2018 and has held it in 24 quarters since.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.